These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 16517174

  • 1. Soluble interleukin-2 receptor in stage I-III melanoma.
    Ottaiano A, Leonardi E, Simeone E, Ascierto PA, Scala S, Calemma R, Bryce J, Caracò C, Satriano RA, Gianfranco N, Franco R, Botti G, Castello G.
    Cytokine; 2006 Feb 07; 33(3):150-5. PubMed ID: 16517174
    [Abstract] [Full Text] [Related]

  • 2. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
    Boyano MD, Garcia-Vázquez MD, López-Michelena T, Gardeazabal J, Bilbao J, Cañavate ML, Galdeano AG, Izu R, Díaz-Ramón L, Raton JA, Díaz-Pérez JL.
    Br J Cancer; 2000 Oct 07; 83(7):847-52. PubMed ID: 10970683
    [Abstract] [Full Text] [Related]

  • 3. [Prognostic factors in patients with stage III and IV non-small cell lung cancer].
    Song LH, Song XR, Liu MQ, Zhang XQ, Zheng L, Li XJ, Liu PX.
    Zhonghua Zhong Liu Za Zhi; 2004 Jun 07; 26(6):345-8. PubMed ID: 15312344
    [Abstract] [Full Text] [Related]

  • 4. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y, Tsurumi H, Sawada M, Yamada T, Hara T, Fukuno K, Goto H, Moriwaki H.
    Rinsho Ketsueki; 1999 Aug 07; 40(8):639-45. PubMed ID: 10496038
    [Abstract] [Full Text] [Related]

  • 5. [Serum soluble interleukin-2 receptor levels in patients with renal cell carcinoma: a comparison of values before and after surgery].
    Tsukamoto S, Ishikawa S, Yamauchi A, Saitou S.
    Hinyokika Kiyo; 2000 Oct 07; 46(10):695-9. PubMed ID: 11215193
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of serum biological markers in patients with hepatocellular carcinoma.
    Parasole R, Izzo F, Perrone F, Pignata S, Galati MG, Leonardi E, Castiglione F, Orlando R, Castello G, Esposito G, Gallo C, Daniele B.
    Clin Cancer Res; 2001 Nov 07; 7(11):3504-9. PubMed ID: 11705869
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W, Chyczewska E, Kovalchuk O, Tałałaj J, Izycki T, Panek B.
    Rocz Akad Med Bialymst; 2004 Nov 07; 49():246-51. PubMed ID: 15631351
    [Abstract] [Full Text] [Related]

  • 8. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
    Gadducci A, Ferdeghini M, Malagnino G, Prontera C, Fanucchi A, Annicchiarico C, Bianchi R, Fioretti P, Facchini V.
    Gynecol Oncol; 1994 Mar 07; 52(3):386-91. PubMed ID: 8157196
    [Abstract] [Full Text] [Related]

  • 9. A long-term analysis of 620 patients with malignant melanoma at a major referral center.
    Averbook BJ, Russo LJ, Mansour EG.
    Surgery; 1998 Oct 07; 124(4):746-55; discussion 755-6. PubMed ID: 9780997
    [Abstract] [Full Text] [Related]

  • 10. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V, Pekmezović T, Adanja B, Jarebinski M, Marinković J, Tomin R.
    Srp Arh Celok Lek; 1997 Oct 07; 125(5-6):132-7. PubMed ID: 9265233
    [Abstract] [Full Text] [Related]

  • 11. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D, Borgognoni L, Franchi A, Martini L, Reali UM, Santucci M.
    Melanoma Res; 2000 Apr 07; 10(2):153-64. PubMed ID: 10803716
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution.
    Roulin D, Matter M, Bady P, Liénard D, Gugerli O, Boubaker A, Bron L, Lejeune FJ.
    Eur J Surg Oncol; 2008 Jun 07; 34(6):673-9. PubMed ID: 17825518
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Significance of soluble interleukin-2 receptor alpha chain in the management of patients with malignant lymphoma: a multi-center study].
    Ohno H, Ishikawa T, Kitajima H, Nomura S, Suzuki T, Konishi H, Ohno Y, Onishi R, Konaka Y, Arima N, Doi S, Nasu K, Takahashi T, Tsudo M, Fukuhara S, Uchiyama T.
    Rinsho Ketsueki; 2002 Mar 07; 43(3):170-5. PubMed ID: 11979748
    [Abstract] [Full Text] [Related]

  • 16. Soluble immunological parameters and early prognosis of renal cell cancer patients.
    Kallio JP, Tammela TL, Marttinen AT, Kellokumpu-Lehtinen PL.
    J Exp Clin Cancer Res; 2001 Dec 07; 20(4):523-8. PubMed ID: 11876546
    [Abstract] [Full Text] [Related]

  • 17. Survival of patients with melanoma of the lower extremity decreases with distance from the trunk.
    Hsueh EC, Lucci A, Qi K, Morton DL.
    Cancer; 1999 Jan 15; 85(2):383-8. PubMed ID: 10023706
    [Abstract] [Full Text] [Related]

  • 18. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D, Mourah S, Kerob D, Verola O, Basset-Seguin N, Baccard M, Schartz N, Ollivaud L, Archimbaud A, Servant JM, Revol M, Toubert ME, Podgorniak MP, Plassa F, Porcher R, Lebbé C.
    Arch Dermatol; 2009 Oct 15; 145(10):1105-13. PubMed ID: 19841396
    [Abstract] [Full Text] [Related]

  • 19. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
    Visús C, Andres R, Mayordomo JI, Martinez-Lorenzo MJ, Murillo L, Sáez-Gutiérrez B, Diestre C, Marcos I, Astier P, Godino J, Carapeto-Marquez de Prado FJ, Larrad L, Tres A.
    Melanoma Res; 2007 Apr 15; 17(2):83-9. PubMed ID: 17496783
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.